PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PBAXU

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/06	06:13	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/22	21:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/18	06:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/16	19:28	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/07	06:11	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/04	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/02	13:16	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/02	05:45	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/02	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/27	05:31	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/16	05:36	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/11	05:06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/04	06:27	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/02	20:12	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/02	20:07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/02	10:54	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/03/28	10:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/03/28	10:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/28	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/27	22:27	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/27	11:37	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/24	07:13	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/21	07:18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/17	09:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/17	09:29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/17	09:28	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/15	02:14	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/15	02:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/13	06:16	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/13	06:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation